Brown M L, Inazu A, Hesler C B, Agellon L B, Mann C, Whitlock M E, Marcel Y L, Milne R W, Koizumi J, Mabuchi H
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032.
Nature. 1989 Nov 23;342(6248):448-51. doi: 10.1038/342448a0.
Plasma high density lipoproteins (HDL) are a negative risk factor for atherosclerosis. Increased HDL is sometimes clustered in families, but a genetic basis has never been clearly documented. The plasma cholesteryl ester transfer protein (CETP) catalyses the transfer of cholesteryl ester from HDL to other lipoproteins and therefore might influence HDL levels. Using monoclonal antibodies, we show that CETP is absent in two Japanese siblings who have markedly increased and enlarged HDL. Furthermore, they are homozygous for a point mutation in the 5'-splice donor site of intron 14 of the gene for CETP, a change that is incompatible with normal splicing of pre-messenger RNA. The results indicate that the family has an inherited deficiency of CETP due to a gene splicing defect, and illustrate the key role that CETP has in human HDL metabolism.
